Responding to the decision to keep everolimus (Afinitor) and eribulin (Halaven) on the Cancer Drugs Fund after an appeal from Novartis and Eisai...

12 March 2015

Responding to new findings from a study led by Cardiff University’s European Cancer Stem Cell Research Institute (Wed 4 March) which suggests that...

4 March 2015

Responding to a new test developed by The Institute of Cancer Research which could predict the type of treatment an individual breast cancer...

27 February 2015

Responding to research showing women back the idea of more breast screens for those at high risk of cancer Samia al Qadhi Chief Executive at...

20 February 2015

Responding to the latest figures from the NHS Breast Screening Programme for England Dr Emma Pennery CBE Clinical Director at Breast Cancer Care...

18 February 2015

Responding to a review of 19 research papers (including six carried out in the UK) funded by Cancer Research UK which reported information on...

11 February 2015

Responding to the announcement that a new test called Oncotype DX which can predict how beneficial chemotherapy will be for some patients will be...

5 February 2015

Baroness Delyth Morgan, Chief Executive at Breast Cancer Campaign, said: The number of people being diagnosed with cancer, including breast...

4 February 2015

Discussing the importance of early detection of breast cancer Jackie Harris Clinical Nurse Specialist at Breast Cancer Care says: “Nearly...

3 February 2015